<DOC>
	<DOCNO>NCT00729235</DOCNO>
	<brief_summary>This clinical investigation device-based open , prospective , multicenter two-arm randomize trial , compare patient treat slow VT zone versus patient treat zone . The device intend use OVATIOTM CRT model 6750 future generation Sorin Group/ ELA Medical device may use provide CE mark . Ethics committees health authority inform prior use new device applicable . All patient 3-zone detection configuration program . The slow VT zone define program detection parameter follow : - Slow VT detection rate : 100 bpm ( rest rate high 80 bpm , recommend adjust parameter : resting rate + 30 bpm ) - VT detection rate : 150 bpm PARAD+ first choice SVT/ST VT discrimination VT zone . The Fast VT VF limit leave investigator 's judgment . Therapy VT , fast VT VF also leave investigator 's judgment . Patients randomize implant slow VT zone program monitor zone ( monitor arm ) therapy program within slow VT zone ( therapy arm ) . The randomization table generate Sorin Group/ELA Medical .</brief_summary>
	<brief_title>Biventricular Tachycardias Outcome Trial</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patient prescribe implantation replacement CRTICD system accordingly relevant currentlyapproved ACC/AHA15 ( August 2005 , Appendix ยงM.10 ) ESC 16 ( Update 2005 , Appendix ยง M.11 ) guideline relevant currentlyapproved local guideline implantation replacement CRTICD . Patient sign consent form he/she receive appropriate mandatory information . Clinical history symptomatic symptomatic slow VT ; Permanent Atrial Fibrillation ( AF ) ; Any contraindication implant replacement CRTICD ; Pt unable attend schedule fup visit implant Centre ; Pt already include another ongoing clinical study ; Pt unable understand objective ITAC04 study ; Pt refuse cooperate ; Pt unable refuse provide informed consent ; Pt minor ( less 18year old ) ; Pt life expectancy le 1 year ; Pt pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Slow VT , CRT-D , ATP therapy</keyword>
	<keyword>Incidence</keyword>
	<keyword>slow VTs</keyword>
	<keyword>CRT-D patient</keyword>
	<keyword>Clinical</keyword>
	<keyword>relevance</keyword>
	<keyword>treatment</keyword>
	<keyword>VTs</keyword>
	<keyword />
	<keyword>2-years</keyword>
	<keyword>follow-up</keyword>
</DOC>